Care Algorithm and Clinic Decision System on Hepatic Rehabilitation in Patients With Liver Cirrhosis

Launched by AKDENIZ UNIVERSITY · May 27, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new mobile health application called ReLiver-N App, designed to help patients with liver cirrhosis improve their health. The app will provide important health education, tools for patients to take an active role in their care, and a system for nurses to assess how patients are doing. The goal is to see how using this app can help with the rehabilitation of patients who have mild to moderate liver cirrhosis.

To participate in this trial, individuals must be 18 years or older, diagnosed with liver cirrhosis at a mild to moderate stage (Child-Pugh A or B), and have a smartphone with internet access. Participants will be divided into two groups: one group will use the ReLiver-N App, while the other group will not have access to the app. The trial will last for 90 days, with regular check-ins every month to track progress. This study is important because it aims to find new ways to support patients in managing their liver health effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with liver cirrhosis Had Child-Pugh A and B categories 18 years of age or older No barriers to verbal or written communication Having internet at home and a smartphone Patients who consented to participate in the study.
• Exclusion Criteria:
• • Had Child-Pugh C category Had pregnant Liver transplanted Diagnosed with hepatocellular carcinoma Having dementia Having been diagnosed with a psychiatric disease